InMode Ltd. (INMD)
NASDAQ: INMD · Real-Time Price · USD
13.94
-0.11 (-0.78%)
At close: Jan 16, 2026, 4:00 PM EST
14.00
+0.06 (0.43%)
After-hours: Jan 16, 2026, 7:50 PM EST
InMode Market Cap
InMode has a market cap or net worth of $881.14 million as of January 16, 2026. Its market cap has decreased by -37.65% in one year.
Market Cap
881.14M
Enterprise Value
354.42M
1-Year Change
-37.65%
Ranking
Category
Stock Price
$13.94
Market Cap Chart
Since August 8, 2019, InMode's market cap has increased from $433.88M to $881.14M, an increase of 103.08%. That is a compound annual growth rate of 11.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 881.14M | -5.11% |
| Dec 31, 2025 | 928.54M | -34.29% |
| Dec 31, 2024 | 1.41B | -23.66% |
| Dec 29, 2023 | 1.85B | -37.59% |
| Dec 30, 2022 | 2.97B | -44.98% |
| Dec 31, 2021 | 5.39B | 218.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |